| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3880752 | The Journal of Urology | 2005 | 6 Pages |
Abstract
The introduction of serum prostate specific antigen testing as a screening tool for prostate cancer along with the advent of less invasive alternatives, including pharmacological therapy, have had a significant impact on the incidence of diagnosed BPH in the last decade.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
ARUNA V. SARMA, DEBRA J. JACOBSON, MICHAELA E. McGREE, ROSEBUD O. ROBERTS, MICHAEL M. LIEBER, STEVEN J. JACOBSEN,